Hypothetical case - For market research purposes only
Learn about DREAMM-7, an ongoing trial evaluating the efficacy and safety of the combination of belantamab mafodotin-blmf and Vd (BVd) compared with the combination of daratumumab and Vd (D-Vd) in patients with RRMM.
${articleImageText}